Literature DB >> 28124259

Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?

Michael Bergman1, Ram Jagannathan2, Martin Buysschaert3, Jose Luis Medina4, Mary Ann Sevick2, Karin Katz5, Brenda Dorcely5, Jesse Roth6, Angela Chetrit7, Rachel Dankner6,7,8.   

Abstract

Identifying the earliest time point on the prediabetic continuum is critical to avoid progressive deterioration in β-cell function. Progressively rising glucose levels even within the "normal range" occur considerably late in the evolution to diabetes thus presenting an important opportunity for earlier diagnosis, treatment, and possible reversal. An elevated 1 h postprandial glucose level, not detected by current diagnostic standards, may provide an opportunity for the early identification of those at risk. When the 1 h post-load glucose level is elevated, lifestyle intervention may have the greatest benefit for preserving β-cell function and prevent further progression to prediabetes and diabetes. In view of the considerable consistent epidemiologic data in large disparate populations supporting the predictive capacity of the1 h post-load value for predicting progression to diabetes and mortality, the time is therefore ripe to evaluate this hypothesis in a large, prospective multicenter randomized trial with lifestyle intervention.

Entities:  

Keywords:  Diabetes; Diabetes prevention; Dysglycemia; Oral glucose tolerance test; Prediabetes

Mesh:

Substances:

Year:  2017        PMID: 28124259     DOI: 10.1007/s12020-017-1236-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  45 in total

Review 1.  Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis.

Authors:  Elizabeth Sumamo Schellenberg; Donna M Dryden; Ben Vandermeer; Christine Ha; Christina Korownyk
Journal:  Ann Intern Med       Date:  2013-10-15       Impact factor: 25.391

2.  One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study.

Authors:  Tae Jung Oh; Soo Lim; Kyoung Min Kim; Jae Hoon Moon; Sung Hee Choi; Young Min Cho; Kyong Soo Park; HakChul Jang; Nam H Cho
Journal:  Clin Endocrinol (Oxf)       Date:  2016-11-28       Impact factor: 3.478

3.  Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.

Authors:  Cristina Bianchi; Roberto Miccoli; Maddalena Trombetta; Francesco Giorgino; Simona Frontoni; Emanuela Faloia; Giulio Marchesini; Maria A Dolci; Franco Cavalot; Gisella Cavallo; Frida Leonetti; Riccardo C Bonadonna; Stefano Del Prato
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

4.  Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts.

Authors:  Akram Alyass; Peter Almgren; Mikael Akerlund; Jonathan Dushoff; Bo Isomaa; Peter Nilsson; Tiinamaija Tuomi; Valeriya Lyssenko; Leif Groop; David Meyre
Journal:  Diabetologia       Date:  2014-10-08       Impact factor: 10.122

Review 5.  Prediabetes and associated disorders.

Authors:  Martin Buysschaert; José Luís Medina; Michael Bergman; Avni Shah; Jaqueline Lonier
Journal:  Endocrine       Date:  2014-10-08       Impact factor: 3.633

6.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

7.  The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia.

Authors:  Ram Jagannathan; Mary Ann Sevick; Dorothy Fink; Rachel Dankner; Angela Chetrit; Jesse Roth; Martin Buysschaert; Michael Bergman
Journal:  Acta Diabetol       Date:  2016-01-21       Impact factor: 4.280

8.  Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.

Authors: 
Journal:  Lancet Diabetes Endocrinol       Date:  2015-09-13       Impact factor: 32.069

9.  Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Bethany Warren; James S Pankow; Kunihiro Matsushita; Naresh M Punjabi; Natalie R Daya; Morgan Grams; Mark Woodward; Elizabeth Selvin
Journal:  Lancet Diabetes Endocrinol       Date:  2016-11-16       Impact factor: 32.069

10.  Predictability of 1-h postload plasma glucose concentration: A 10-year retrospective cohort study.

Authors:  Lifen Kuang; Zhimin Huang; Zhenzhen Hong; Ailing Chen; Yanbing Li
Journal:  J Diabetes Investig       Date:  2015-04-27       Impact factor: 4.232

View more
  2 in total

1.  Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion.

Authors:  Rita S Patarrão; Nádia Duarte; Inês Coelho; Joey Ward; Rogério T Ribeiro; Maria João Meneses; Rita Andrade; João Costa; Isabel Correia; José Manuel Boavida; Rui Duarte; Luís Gardete-Correia; José Luís Medina; Jill Pell; John Petrie; João F Raposo; Maria Paula Macedo; Carlos Penha-Gonçalves
Journal:  Diabetologia       Date:  2022-02-22       Impact factor: 10.122

Review 2.  Novel biomarkers for prediabetes, diabetes, and associated complications.

Authors:  Brenda Dorcely; Karin Katz; Ram Jagannathan; Stephanie S Chiang; Babajide Oluwadare; Ira J Goldberg; Michael Bergman
Journal:  Diabetes Metab Syndr Obes       Date:  2017-08-14       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.